Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
Carolyn M Roos, Bin Zhang, Allyson K. Palmer, et al.
Aging Cell (2016) Vol. 15, Iss. 5, pp. 973-977
Open Access | Times Cited: 643

Showing 1-25 of 643 citing articles:

Senolytics improve physical function and increase lifespan in old age
Ming Xu, Tamar Pirtskhalava, Joshua N. Farr, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1246-1256
Open Access | Times Cited: 1772
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Raffaella Di Micco, Valery Krizhanovsky, Darren J. Baker, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 22, Iss. 2, pp. 75-95
Open Access | Times Cited: 1450
Senescence in Health and Disease
Shenghui He, Norman E. Sharpless
Cell (2017) Vol. 169, Iss. 6, pp. 1000-1011
Open Access | Times Cited: 1430
Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer, Thomas A. White, Koji Iijima, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1230
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Lars Larsson, Hans Degens, Meishan Li, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 427-511
Open Access | Times Cited: 1190
Senescent cells: an emerging target for diseases of ageing
Bennett G. Childs, Martina Gluscevic, Darren J. Baker, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 10, pp. 718-735
Open Access | Times Cited: 1013
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J. Hickson, Larissa Prata, Shane A. Bobart, et al.
EBioMedicine (2019) Vol. 47, pp. 446-456
Open Access | Times Cited: 957
Targeting cellular senescence prevents age-related bone loss in mice
Joshua N. Farr, Ming Xu, Megan Weivoda, et al.
Nature Medicine (2017) Vol. 23, Iss. 9, pp. 1072-1079
Open Access | Times Cited: 932
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Jamie N. Justice, Anoop M. Nambiar, Tamar Tchkonia, et al.
EBioMedicine (2019) Vol. 40, pp. 554-563
Open Access | Times Cited: 932
Cellular Senescence: A Translational Perspective
James L. Kirkland, Tamar Tchkonia
EBioMedicine (2017) Vol. 21, pp. 21-28
Open Access | Times Cited: 841
Cellular senescence drives age-dependent hepatic steatosis
Mikołaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 830
Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness
Andrew Durham, Mei Y. Speer, Marta Scatena, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 4, pp. 590-600
Open Access | Times Cited: 818
Senolytic drugs: from discovery to translation
James L. Kirkland, Tamar Tchkonia
Journal of Internal Medicine (2020) Vol. 288, Iss. 5, pp. 518-536
Open Access | Times Cited: 775
Fisetin is a senotherapeutic that extends health and lifespan
Matthew J. Yousefzadeh, Yi Zhu, Sara J. McGowan, et al.
EBioMedicine (2018) Vol. 36, pp. 18-28
Open Access | Times Cited: 759
Epigenetics and aging
Sangita Pal, Jessica K. Tyler
Science Advances (2016) Vol. 2, Iss. 7
Open Access | Times Cited: 696
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690
Mechanisms of Vascular Aging
Zoltán Ungvári, Stefano Tarantini, Anthony J. Donato, et al.
Circulation Research (2018) Vol. 123, Iss. 7, pp. 849-867
Open Access | Times Cited: 686
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 924-967
Open Access | Times Cited: 667
Cellular senescence and senolytics: the path to the clinic
Selim Chaib, Tamar Tchkonia, James L. Kirkland
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1556-1568
Open Access | Times Cited: 626
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Yi Zhu, Ewald J. Doornebal, Tamar Pirtskhalava, et al.
Aging (2017) Vol. 9, Iss. 3, pp. 955-963
Open Access | Times Cited: 598
Identification of HSP90 inhibitors as a novel class of senolytics
Heike Fuhrmann‐Stroissnigg, Yuan Yuan Ling, Jing Zhao, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 583
The effects of aging in the hippocampus and cognitive decline
Luis E.B. Bettio, Luckshi Rajendran, Joana Gil‐Mohapel
Neuroscience & Biobehavioral Reviews (2017) Vol. 79, pp. 66-86
Closed Access | Times Cited: 512
Targeting senescent cells alleviates obesity‐induced metabolic dysfunction
Allyson K. Palmer, Ming Xu, Yi Zhu, et al.
Aging Cell (2019) Vol. 18, Iss. 3
Open Access | Times Cited: 491
The Clinical Potential of Senolytic Drugs
James L. Kirkland, Tamar Tchkonia, Yi Zhu, et al.
Journal of the American Geriatrics Society (2017) Vol. 65, Iss. 10, pp. 2297-2301
Open Access | Times Cited: 489
Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis
Mandy O. J. Grootaert, Manon Moulis, Lynn Roth, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 4, pp. 622-634
Open Access | Times Cited: 478
Page 1 - Next Page

Scroll to top